Christopher Wright
Direktor/Vorstandsmitglied bei ALKERMES PLC
Vermögen: 228 782 $ am 31.05.2024
Aktive Positionen von Christopher Wright
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ALKERMES PLC | Direktor/Vorstandsmitglied | 24.05.2022 | - |
| Independent Dir/Board Member | 24.05.2022 | - | |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Karriereverlauf von Christopher Wright
Ehemalige bekannte Positionen von Christopher Wright
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CYCLERION THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - | 26.03.2021 |
Aavantibio, Inc.
 Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
| Harvard Medical School | Corporate Officer/Principal | - | - |
| IRONWOOD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.01.2017 | - |
| AXCA HEALPAR | Technik-/Wissenschafts-/F&E-Leiter | - | - |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | - | - |
Ausbildung von Christopher Wright
| Harvard University | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
| Vrije Universiteit Amsterdam | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 9 |
| Niederlande | 2 |
| Irland | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 4 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 2 |
Sektoral
| Health Technology | 8 |
| Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| AXCA HEALPAR | Health Technology |
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| CYCLERION THERAPEUTICS, INC. | Health Technology |
| ALKERMES PLC | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL. | Health Technology |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Christopher Wright
- Erfahrung